ZNF235 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.667800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.436800E-01
Normal-vs-Stage2
5.964200E-02
Normal-vs-Stage3
8.441800E-02
Normal-vs-Stage4
3.360200E-01
Stage1-vs-Stage2
1.791170E-01
Stage1-vs-Stage3
1.148440E-01
Stage1-vs-Stage4
5.797600E-01
Stage2-vs-Stage3
3.396400E-01
Stage2-vs-Stage4
7.262400E-01
Stage3-vs-Stage4
2.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.035600E-02
Normal-vs-AfricanAmerican
7.252100E-02
Normal-vs-Asian
7.718500E-02
Caucasian-vs-AfricanAmerican
4.963000E-01
Caucasian-vs-Asian
4.368800E-01
AfricanAmerican-vs-Asian
9.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.110630E-01
Normal-vs-Female
1.787820E-02
Male-vs-Female
6.159600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.799000E-01
Normal-vs-Age(41-60Yrs)
2.138600E-01
Normal-vs-Age(61-80Yrs)
2.536300E-02
Normal-vs-Age(81-100Yrs)
2.341000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.269600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.337800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.289000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.396700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.520300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.883900E-02
Normal-vs-Daily Drinker
2.329800E-01
Normal-vs-Weekly Drinker
4.681900E-02
Normal-vs-Occasional Drinker
2.412400E-01
Normal-vs-Social Drinker
3.227800E-01
Non Drinker-vs-Daily Drinker
5.192400E-01
Non Drinker-vs-Weekly Drinker
8.430000E-01
Non Drinker-vs-Occasional Drinker
7.244100E-02
Non Drinker-vs-Social Drinker
3.841800E-01
Daily Drinker-vs-Weekly Drinker
6.511200E-01
Daily Drinker-vs-Occasional Drinker
4.735400E-01
Daily Drinker-vs-Social Drinker
9.955000E-01
Weekly Drinker-vs-Occasional Drinker
1.700960E-01
Weekly Drinker-vs-Social Drinker
5.251200E-01
Occasional Drinker-vs-Social Drinker
3.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.399370E-01
Normal-vs-Grade 2
1.153750E-02
Normal-vs-Grade 3
1.901960E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.965800E-01
Grade 1-vs-Grade 3
9.443200E-01
Grade 1-vs-Grade 4
1.399370E-01
Grade 2-vs-Grade 3
1.535390E-01
Grade 2-vs-Grade 4
1.153750E-02
Grade 3-vs-Grade 4
1.901960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.341700E-03
Normal-vs-NonDiabetic
8.366300E-02
Diabetic-vs-NonDiabetic
2.794300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.437200E-01
Normal-vs-NoPancreatitis
1.653780E-02
Pancreatitis-vs-NoPancreatitis
5.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.296000E-02
Normal-vs-N1
5.877700E-02
N0-vs-N1
8.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.462800E-01
Normal-vs-TP53-NonMutant
2.632600E-01
TP53-Mutant-vs-TP53-NonMutant
6.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
